Amanote Research
Register
Sign In
Drug Trial Investigators Asked to Declare Financial Interests
BMJ
doi 10.1136/bmj.318.7187.831
Full Text
Open PDF
Abstract
Available in
full text
Date
March 27, 1999
Authors
A. Ferriman
Publisher
BMJ
Related search
Nothing to Declare?
Nature Methods
Biochemistry
Biotechnology
Cell Biology
Molecular Biology
GPs Asked Not to Demand Payments From Drug Company Representatives
BMJ
Cash Interests Taint Drug Advice
Nature
Multidisciplinary
Generic Substitution, Financial Interests, and Imperfect Agency
International Journal of Health Care Finance and Economics
PHP95 Prescription Monitoring Program Effectiveness: Perceptions of Drug Diversion Investigators
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
DECLARE-TIMI 58 Trial in the Context of EMPA-REG OUTCOME and CANVAS
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
How Do Parents Experience Being Asked to Enter a Child in a Randomised Controlled Trial?
BMC Medical Ethics
Health Policy
Ethics
Health
Issues
Legal Aspects
An Ontology to Semantically Declare and Describe Functions
Lecture Notes in Computer Science
Computer Science
Theoretical Computer Science
Landed Interests and Financial Underdevelopment in the United States
SSRN Electronic Journal